A number of firms have modified their ratings and price targets on shares of Bruker (NASDAQ: BRKR) recently:
- 5/11/2026 – Bruker was downgraded by Weiss Ratings from “sell (d+)” to “sell (d)”.
- 5/9/2026 – Bruker was upgraded by Wall Street Zen from “hold” to “buy”.
- 5/8/2026 – Bruker was given a new $45.00 price target by Stifel Nicolaus.
- 5/7/2026 – Bruker had its price target raised by TD Cowen from $43.00 to $45.00. They now have a “hold” rating on the stock.
- 5/7/2026 – Bruker had its price target raised by UBS Group AG from $40.00 to $45.00. They now have a “neutral” rating on the stock.
- 5/7/2026 – Bruker had its price target raised by Citigroup Inc. from $40.00 to $44.00. They now have a “neutral” rating on the stock.
- 5/7/2026 – Bruker had its price target raised by Barclays PLC from $45.00 to $53.00. They now have an “overweight” rating on the stock.
- 4/24/2026 – Bruker was upgraded by Weiss Ratings from “sell (d)” to “sell (d+)”.
- 4/14/2026 – Bruker had its price target lowered by Barclays PLC from $50.00 to $45.00. They now have an “overweight” rating on the stock.
- 4/13/2026 – Bruker was upgraded by TD Cowen to “hold”.
- 3/30/2026 – Bruker had its price target lowered by Guggenheim from $58.00 to $50.00. They now have a “buy” rating on the stock.
- 3/27/2026 – Bruker had its “sell (d+)” rating reaffirmed by Weiss Ratings.
Bruker Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 7th. Investors of record on Monday, June 22nd will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, June 22nd. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.5%. Bruker’s dividend payout ratio (DPR) is presently -83.33%.
Insider Buying and Selling at Bruker
In other Bruker news, VP Mark Munch sold 2,000 shares of the stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $39.90, for a total transaction of $79,800.00. Following the sale, the vice president directly owned 128,443 shares in the company, valued at $5,124,875.70. This represents a 1.53% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 27.20% of the company’s stock.
Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.
Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.
In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.
See Also
- Five stocks we like better than Bruker
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for Bruker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
